Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed at $3.00 down -9.09% from its previous closing price of $3.30. In other words, the price has decreased by -$9.09 from its previous closing price. On the day, 0.94 million shares were traded.
Ratios:
For a deeper understanding of Amylyx Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.55. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 03 ’25 when Mazzariello Gina sold 3,678 shares for $3.49 per share. The transaction valued at 12,839 led to the insider holds 139,090 shares of the business.
Cohen Joshua B sold 11,851 shares of AMLX for $41,108 on Feb 03 ’25. The Co-Chief Executive Officer now owns 3,201,247 shares after completing the transaction at $3.47 per share. On Feb 03 ’25, another insider, Klee Justin B., who serves as the Co-Chief Executive Officer of the company, sold 11,855 shares for $3.47 each. As a result, the insider received 41,104 and left with 3,164,933 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.31 while its Price-to-Book (P/B) ratio in mrq is 1.05.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $19.95, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -19.41%, while the 200-Day Moving Average is calculated to be -5.58%.
Shares Statistics:
A total of 68.55M shares are outstanding, with a floating share count of 49.79M. Insiders hold about 27.36% of the company’s shares, while institutions hold 72.98% stake in the company.
